44 participants
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-15
- Start Date:
- 2021-08-16
- Completion:
- 2024-01-15
Conditions
- Neoplasm Malignant
- Breast Cancer
- Lung Neoplasm Malignant
- Gastric Cancer
- Neoplasm
Interventions
- DRUG
No Results Yet